More Articles Back to Article
CureVac secures $85M loan to build COVID-19 vaccine plant
Germany's CureVac has secured an $85 million loan from the European Investment Bank to expedite the completion of a fourth manufacturing facility for an mRNA-based COVID-19 vaccine under development. The company is preparing an initial public offering in the US this month. Reuters (7/6)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!